Related Experiment Video
Updated: Jan 20, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Curcumin inhibits cell proliferation and migration in NSCLC through a synergistic effect on the TLR4/MyD88 and EGFR
Lanfeng Zhang1, Xingyu Tao1, Qiaofen Fu2
1Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong 510315, P.R. China.
Abstract:
Despite the increasing number of available therapeutic methods, the prognosis of non‑small cell lung cancer (NSCLC) remains poor. Furthermore, side effects are an important limiting factor in the treatment of NSCLC. Therefore, developing an efficacious, safe, affordable and easily accessible chemotherapeutic agent is necessary for NSCLC treatment. As a natural chemical produced by Zingiberaceae plants, curcumin exerts distinct antitumor effects on several tumor types. In the present study, curcumin was observed to inhibit not only cell proliferation and cell cycle transition, but also cell migration in NSCLC, as determined by a series of experiments (such as MTS assay, colony formation assay, flow cytometric analysis, Transwell migration assay and western blotting). Mechanistically, curcumin induced G2/M phase arrest by controlling cell cycle‑ and epithelial‑mesenchymal transition (EMT)‑related checkpoints. Furthermore, curcumin significantly inhibited the expression of Toll‑like receptor 4 (TLR4)/MyD88 and EGFR in a dose‑ and time‑dependent manner. Conversely, EGF reversed the inhibitory action of curcumin on TLR4/MyD88. In clinical specimens, TLR4 and MyD88 were highly expressed in NSCLC tissues, and a significant positive association was observed between TLR4 and MyD88 expression. These data suggested that curcumin may control the EGFR and TLR4/MyD88 pathways to synergistically downregulate downstream cell cycle‑ and EMT‑related regulators, in order to block cell proliferation and metastasis in NSCLC. These findings provide evidence for the clinical application of curcumin.
Insights
Curcumin, a natural compound, effectively inhibits non-small cell lung cancer (NSCLC) proliferation and metastasis. It targets cell cycle and epithelial-mesenchymal transition pathways, offering a potential new treatment for NSCLC.
Area of Science:
- Oncology
- Natural Products Chemistry
- Molecular Biology
Background:
- Non-small cell lung cancer (NSCLC) has a poor prognosis despite available treatments.
- Treatment side effects and accessibility are significant challenges in NSCLC therapy.
- Curcumin, derived from Zingiberaceae plants, shows potential antitumor properties.
Purpose of the Study:
- To investigate the efficacy and mechanisms of curcumin in inhibiting NSCLC progression.
- To explore curcumin's effects on cell proliferation, cell cycle, and migration in NSCLC.
- To elucidate the molecular pathways targeted by curcumin in NSCLC.
Main Methods:
- In vitro assays including MTS, colony formation, flow cytometry, and Transwell migration.
- Western blotting to analyze protein expression.
- Analysis of clinical NSCLC specimens.
Main Results:
- Curcumin inhibited NSCLC cell proliferation, cell cycle transition (G2/M arrest), and migration.
- Curcumin suppressed the expression of Toll-like receptor 4 (TLR4)/MyD88 and EGFR.
- High expression of TLR4 and MyD88 was observed in NSCLC tissues, correlating positively.
Conclusions:
- Curcumin demonstrates significant antitumor activity against NSCLC by targeting cell cycle and epithelial-mesenchymal transition.
- The EGFR and TLR4/MyD88 pathways are implicated in curcumin's anti-NSCLC effects.
- Curcumin presents a promising, natural therapeutic agent for NSCLC treatment.
More Related Videos
Related Concept Videos
Feedback Inhibition
Cell Migration
Cell Migration
Cells Coordinate Growth and Proliferation
Abnormal Proliferation
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...

